glucagon agonist retatrutide triple gip glp-1 phase 3 2025 Dual and Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Retatrutide (Triple GLP-1/GIP/Glucagon Agonist) Research

Heres what you need to know before you buy

EmFace lifts and tightens skin to help you achieve a younger-looking appearance

When comparing semaglutide versus Ozempic pen, its important to understand that Ozempic specifically uses semaglutide to help control blood sugar in adults with type 2 diabetes

First, SELECT was designed as a CV outcomes trial and not a weight-loss trial, and weight loss was only a supportive secondary endpoint in the trial design

ZepBound, launched for obesity in late 2023, quickly added hundreds of millions in sales by mid-2025, its global sales were already in the hundreds of millions as clinics rolled out the new weight-loss injection